Pathstone Family Office’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Pathstone Family Office’s Portfolio BMEZ Stock Details BMEZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$214K	Buy	14,845 +412	+3%	+$6.42K	﹤0.01%	1476
2023 Q2	$237K	Buy	14,433 +381	+3%	+$6.21K	﹤0.01%	1073
2023 Q1	$235K	Sell	14,052 -13,310	-49%	-$214K	﹤0.01%	1021
2022 Q4	$411K	Buy	27,362 +746	+3%	+$11.6K	﹤0.01%	1178
2022 Q3	$398K	Buy	26,616 +13,710	+106%	+$227K	﹤0.01%	1157
2022 Q2	$212K	Buy	12,906 +329	+3%	+$5.64K	﹤0.01%	942
2022 Q1	$252K	Buy	12,577 +274	+2%	+$5.69K	0.01%	820
2021 Q4	$312K	Buy	12,303 +238	+2%	+$6.14K	0.01%	696
2021 Q3	$326K	Buy	12,065 +188	+2%	+$5.38K	0.01%	650
2021 Q2	$343K	Buy	11,877 +182	+2%	+$5.04K	0.01%	596
2021 Q1	$308K	Buy	11,695 +145	+1%	+$4.11K	0.01%	476
2020 Q4	$331K	Buy	+11,550	New	+$307K	0.01%	215

Other funds holding BMEZ

SCM

Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

1CP

1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

KIM

Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Pathstone Family Office's BMEZ Position: Q3 2023 in Review

Pathstone Family Office increased its BlackRock Health Sciences Trust II (BMEZ) stake by 2.9% in Q3 2023, buying an estimated $6.42K and bringing the position to 14,845 shares worth $214K. The position accounts for ﹤0.01% of the portfolio, ranked #1476.

Pathstone Family Office first reported a position in BMEZ in Q4 2020 and has held it in 12 quarters since. The position peaked at $411K in Q4 2022. 98 funds tracked by Wall St. Rank hold BMEZ as of Q3 2023.

Pathstone Family Office held 14,845 shares of BlackRock Health Sciences Trust II worth $214K as of Q3 2023.
Pathstone Family Office bought 412 BlackRock Health Sciences Trust II shares in Q3 2023, an estimated $6.42K.
BlackRock Health Sciences Trust II made up ﹤0.01% of Pathstone Family Office's portfolio in Q3 2023, its #1476 holding.
Pathstone Family Office first reported a position in BlackRock Health Sciences Trust II in Q4 2020 and has held it in 12 quarters since.
Pathstone Family Office's BlackRock Health Sciences Trust II position peaked at $411K in Q4 2022.
98 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q3 2023.

Based on Pathstone Family Office's 13F filing for Q3 2023, filed 8 Nov 2023.